MohamedSheblAbdelBakiMD

Clinical Trials

• Intra-tumoral Injection of Natural Killer Cells in High-Grade Gliomas Start of enrollment: 2023 Dec 01

  Not yet recruiting

  Phase 1

• Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors Start of enrollment: 2021 Dec 03

  Recruiting

  Phase 1

  Roles: Principal Investigator

• REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma Start of enrollment: 2018 Sep 24

  Terminated

  Phase 1, Phase 2

  Roles: Contact

• Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma Start of enrollment: 2022 Feb 22

  Recruiting

  Not Applicable

  Roles: Contact, Principal Investigator

• Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) Start of enrollment: 2020 Dec 09

  Recruiting

  Phase 1

  Roles: Contact

• BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas Start of enrollment: 2019 Apr 03

  Recruiting

  Phase 1

  Roles: Principal Investigator, Contact

• Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults Start of enrollment: 2020 Oct 02

  Recruiting

  Phase 1

  Roles: Contact

• Join now to see all